aluates Reports

$ 0.0

Automative

Global Immuno-Oncology Service Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-6H18590

BUY CHAPTERS

Global Immuno-Oncology Service Market Research Report 2024

Code: QYRE-Auto-6H18590

Report

October 2024

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Crown Bioscience

Bio-Techne

Abcam

WuXi AppTec

Shanghai ChemPartner

George Clinical

Laboratory Corporation of America Holdings

Medpace

GenScript

Lide

TransCure Bioservices

Shanghai Novamab Biopharmaceuticals

Immuno-Oncology Service Market

Immuno-oncology describes the process of harnessing a patient's own immune system to fight cancer. Over the past decade, immuno-oncology has become an exciting cancer treatment approach due to its specificity, adaptability, and durability. Immuno-oncology services provide a one-stop platform to accelerate immuno-oncology research, including target selection, clinical trials, and monitoring and evaluation services.

The global Immuno-Oncology Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Immuno-Oncology Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immuno-Oncology Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Immuno-Oncology Service in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Immuno-Oncology Service include Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, George Clinical, Laboratory Corporation of America® Holdings, Medpace, Genscript, Shanghai Novamab Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology Service.

The Immuno-Oncology Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno-Oncology Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immuno-Oncology Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immuno-Oncology Service Market Report

Report Metric	Details
Report Name	Immuno-Oncology Service Market
Segment by Type	Basic Research Clinical Research
Segment by Application	Pharmaceutical Companies Medical Device Companies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, George Clinical, Laboratory Corporation of America® Holdings, Medpace, Genscript, Shanghai Novamab Biopharmaceuticals, LIDE, TransCure bioServices
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immuno-Oncology Service Market report?

Ans: The main players in the Immuno-Oncology Service Market are Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, George Clinical, Laboratory Corporation of America® Holdings, Medpace, Genscript, Shanghai Novamab Biopharmaceuticals, LIDE, TransCure bioServices

What are the Application segmentation covered in the Immuno-Oncology Service Market report?

Ans: The Applications covered in the Immuno-Oncology Service Market report are Pharmaceutical Companies, Medical Device Companies, Other

What are the Type segmentation covered in the Immuno-Oncology Service Market report?

Ans: The Types covered in the Immuno-Oncology Service Market report are Basic Research, Clinical Research

Recommended Reports

Immuno-Oncology Therapy

Cancer Diagnostics

Cancer Treatment Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immuno-Oncology Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Basic Research

1.2.3 Clinical Research

1.3 Market by Application

1.3.1 Global Immuno-Oncology Service Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical Companies

1.3.3 Medical Device Companies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immuno-Oncology Service Market Perspective (2019-2030)

2.2 Global Immuno-Oncology Service Growth Trends by Region

2.2.1 Global Immuno-Oncology Service Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immuno-Oncology Service Historic Market Size by Region (2019-2024)

2.2.3 Immuno-Oncology Service Forecasted Market Size by Region (2025-2030)

2.3 Immuno-Oncology Service Market Dynamics

2.3.1 Immuno-Oncology Service Industry Trends

2.3.2 Immuno-Oncology Service Market Drivers

2.3.3 Immuno-Oncology Service Market Challenges

2.3.4 Immuno-Oncology Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immuno-Oncology Service Players by Revenue

3.1.1 Global Top Immuno-Oncology Service Players by Revenue (2019-2024)

3.1.2 Global Immuno-Oncology Service Revenue Market Share by Players (2019-2024)

3.2 Global Immuno-Oncology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Immuno-Oncology Service Revenue

3.4 Global Immuno-Oncology Service Market Concentration Ratio

3.4.1 Global Immuno-Oncology Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Service Revenue in 2023

3.5 Global Key Players of Immuno-Oncology Service Head office and Area Served

3.6 Global Key Players of Immuno-Oncology Service, Product and Application

3.7 Global Key Players of Immuno-Oncology Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Oncology Service Breakdown Data by Type

4.1 Global Immuno-Oncology Service Historic Market Size by Type (2019-2024)

4.2 Global Immuno-Oncology Service Forecasted Market Size by Type (2025-2030)

5 Immuno-Oncology Service Breakdown Data by Application

5.1 Global Immuno-Oncology Service Historic Market Size by Application (2019-2024)

5.2 Global Immuno-Oncology Service Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immuno-Oncology Service Market Size (2019-2030)

6.2 North America Immuno-Oncology Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Immuno-Oncology Service Market Size by Country (2019-2024)

6.4 North America Immuno-Oncology Service Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immuno-Oncology Service Market Size (2019-2030)

7.2 Europe Immuno-Oncology Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Immuno-Oncology Service Market Size by Country (2019-2024)

7.4 Europe Immuno-Oncology Service Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immuno-Oncology Service Market Size (2019-2030)

8.2 Asia-Pacific Immuno-Oncology Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Immuno-Oncology Service Market Size by Region (2019-2024)

8.4 Asia-Pacific Immuno-Oncology Service Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immuno-Oncology Service Market Size (2019-2030)

9.2 Latin America Immuno-Oncology Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Immuno-Oncology Service Market Size by Country (2019-2024)

9.4 Latin America Immuno-Oncology Service Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immuno-Oncology Service Market Size (2019-2030)

10.2 Middle East & Africa Immuno-Oncology Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Immuno-Oncology Service Market Size by Country (2019-2024)

10.4 Middle East & Africa Immuno-Oncology Service Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Crown Bioscience

11.1.1 Crown Bioscience Company Details

11.1.2 Crown Bioscience Business Overview

11.1.3 Crown Bioscience Immuno-Oncology Service Introduction

11.1.4 Crown Bioscience Revenue in Immuno-Oncology Service Business (2019-2024)

11.1.5 Crown Bioscience Recent Development

11.2 Bio-Techne

11.2.1 Bio-Techne Company Details

11.2.2 Bio-Techne Business Overview

11.2.3 Bio-Techne Immuno-Oncology Service Introduction

11.2.4 Bio-Techne Revenue in Immuno-Oncology Service Business (2019-2024)

11.2.5 Bio-Techne Recent Development

11.3 Abcam

11.3.1 Abcam Company Details

11.3.2 Abcam Business Overview

11.3.3 Abcam Immuno-Oncology Service Introduction

11.3.4 Abcam Revenue in Immuno-Oncology Service Business (2019-2024)

11.3.5 Abcam Recent Development

11.4 WuXi AppTec

11.4.1 WuXi AppTec Company Details

11.4.2 WuXi AppTec Business Overview

11.4.3 WuXi AppTec Immuno-Oncology Service Introduction

11.4.4 WuXi AppTec Revenue in Immuno-Oncology Service Business (2019-2024)

11.4.5 WuXi AppTec Recent Development

11.5 Shanghai ChemPartner

11.5.1 Shanghai ChemPartner Company Details

11.5.2 Shanghai ChemPartner Business Overview

11.5.3 Shanghai ChemPartner Immuno-Oncology Service Introduction

11.5.4 Shanghai ChemPartner Revenue in Immuno-Oncology Service Business (2019-2024)

11.5.5 Shanghai ChemPartner Recent Development

11.6 George Clinical

11.6.1 George Clinical Company Details

11.6.2 George Clinical Business Overview

11.6.3 George Clinical Immuno-Oncology Service Introduction

11.6.4 George Clinical Revenue in Immuno-Oncology Service Business (2019-2024)

11.6.5 George Clinical Recent Development

11.7 Laboratory Corporation of America® Holdings

11.7.1 Laboratory Corporation of America® Holdings Company Details

11.7.2 Laboratory Corporation of America® Holdings Business Overview

11.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Introduction

11.7.4 Laboratory Corporation of America® Holdings Revenue in Immuno-Oncology Service Business (2019-2024)

11.7.5 Laboratory Corporation of America® Holdings Recent Development

11.8 Medpace

11.8.1 Medpace Company Details

11.8.2 Medpace Business Overview

11.8.3 Medpace Immuno-Oncology Service Introduction

11.8.4 Medpace Revenue in Immuno-Oncology Service Business (2019-2024)

11.8.5 Medpace Recent Development

11.9 Genscript

11.9.1 Genscript Company Details

11.9.2 Genscript Business Overview

11.9.3 Genscript Immuno-Oncology Service Introduction

11.9.4 Genscript Revenue in Immuno-Oncology Service Business (2019-2024)

11.9.5 Genscript Recent Development

11.10 Shanghai Novamab Biopharmaceuticals

11.10.1 Shanghai Novamab Biopharmaceuticals Company Details

11.10.2 Shanghai Novamab Biopharmaceuticals Business Overview

11.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Introduction

11.10.4 Shanghai Novamab Biopharmaceuticals Revenue in Immuno-Oncology Service Business (2019-2024)

11.10.5 Shanghai Novamab Biopharmaceuticals Recent Development

11.11 LIDE

11.11.1 LIDE Company Details

11.11.2 LIDE Business Overview

11.11.3 LIDE Immuno-Oncology Service Introduction

11.11.4 LIDE Revenue in Immuno-Oncology Service Business (2019-2024)

11.11.5 LIDE Recent Development

11.12 TransCure bioServices

11.12.1 TransCure bioServices Company Details

11.12.2 TransCure bioServices Business Overview

11.12.3 TransCure bioServices Immuno-Oncology Service Introduction

11.12.4 TransCure bioServices Revenue in Immuno-Oncology Service Business (2019-2024)

11.12.5 TransCure bioServices Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Crown Bioscience

Bio-Techne

Abcam

WuXi AppTec

Shanghai ChemPartner

George Clinical

Laboratory Corporation of America Holdings

Medpace

GenScript

Lide

TransCure Bioservices

Shanghai Novamab Biopharmaceuticals

List of Tables

Table 1. Global Immuno-Oncology Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Basic Research

Table 3. Key Players of Clinical Research

Table 4. Global Immuno-Oncology Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Immuno-Oncology Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Immuno-Oncology Service Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Immuno-Oncology Service Market Share by Region (2019-2024)

Table 8. Global Immuno-Oncology Service Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Immuno-Oncology Service Market Share by Region (2025-2030)

Table 10. Immuno-Oncology Service Market Trends

Table 11. Immuno-Oncology Service Market Drivers

Table 12. Immuno-Oncology Service Market Challenges

Table 13. Immuno-Oncology Service Market Restraints

Table 14. Global Immuno-Oncology Service Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Immuno-Oncology Service Market Share by Players (2019-2024)

Table 16. Global Top Immuno-Oncology Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Service as of 2023)

Table 17. Ranking of Global Top Immuno-Oncology Service Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Immuno-Oncology Service Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Immuno-Oncology Service, Headquarters and Area Served

Table 20. Global Key Players of Immuno-Oncology Service, Product and Application

Table 21. Global Key Players of Immuno-Oncology Service, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Immuno-Oncology Service Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Immuno-Oncology Service Revenue Market Share by Type (2019-2024)

Table 25. Global Immuno-Oncology Service Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Immuno-Oncology Service Revenue Market Share by Type (2025-2030)

Table 27. Global Immuno-Oncology Service Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Immuno-Oncology Service Revenue Market Share by Application (2019-2024)

Table 29. Global Immuno-Oncology Service Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Immuno-Oncology Service Revenue Market Share by Application (2025-2030)

Table 31. North America Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Immuno-Oncology Service Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Immuno-Oncology Service Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Immuno-Oncology Service Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Immuno-Oncology Service Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Immuno-Oncology Service Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Immuno-Oncology Service Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Immuno-Oncology Service Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Immuno-Oncology Service Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Immuno-Oncology Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Immuno-Oncology Service Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Immuno-Oncology Service Market Size by Country (2025-2030) & (US$ Million)

Table 46. Crown Bioscience Company Details

Table 47. Crown Bioscience Business Overview

Table 48. Crown Bioscience Immuno-Oncology Service Product

Table 49. Crown Bioscience Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 50. Crown Bioscience Recent Development

Table 51. Bio-Techne Company Details

Table 52. Bio-Techne Business Overview

Table 53. Bio-Techne Immuno-Oncology Service Product

Table 54. Bio-Techne Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 55. Bio-Techne Recent Development

Table 56. Abcam Company Details

Table 57. Abcam Business Overview

Table 58. Abcam Immuno-Oncology Service Product

Table 59. Abcam Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 60. Abcam Recent Development

Table 61. WuXi AppTec Company Details

Table 62. WuXi AppTec Business Overview

Table 63. WuXi AppTec Immuno-Oncology Service Product

Table 64. WuXi AppTec Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 65. WuXi AppTec Recent Development

Table 66. Shanghai ChemPartner Company Details

Table 67. Shanghai ChemPartner Business Overview

Table 68. Shanghai ChemPartner Immuno-Oncology Service Product

Table 69. Shanghai ChemPartner Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 70. Shanghai ChemPartner Recent Development

Table 71. George Clinical Company Details

Table 72. George Clinical Business Overview

Table 73. George Clinical Immuno-Oncology Service Product

Table 74. George Clinical Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 75. George Clinical Recent Development

Table 76. Laboratory Corporation of America® Holdings Company Details

Table 77. Laboratory Corporation of America® Holdings Business Overview

Table 78. Laboratory Corporation of America® Holdings Immuno-Oncology Service Product

Table 79. Laboratory Corporation of America® Holdings Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 80. Laboratory Corporation of America® Holdings Recent Development

Table 81. Medpace Company Details

Table 82. Medpace Business Overview

Table 83. Medpace Immuno-Oncology Service Product

Table 84. Medpace Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 85. Medpace Recent Development

Table 86. Genscript Company Details

Table 87. Genscript Business Overview

Table 88. Genscript Immuno-Oncology Service Product

Table 89. Genscript Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 90. Genscript Recent Development

Table 91. Shanghai Novamab Biopharmaceuticals Company Details

Table 92. Shanghai Novamab Biopharmaceuticals Business Overview

Table 93. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product

Table 94. Shanghai Novamab Biopharmaceuticals Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 95. Shanghai Novamab Biopharmaceuticals Recent Development

Table 96. LIDE Company Details

Table 97. LIDE Business Overview

Table 98. LIDE Immuno-Oncology Service Product

Table 99. LIDE Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 100. LIDE Recent Development

Table 101. TransCure bioServices Company Details

Table 102. TransCure bioServices Business Overview

Table 103. TransCure bioServices Immuno-Oncology Service Product

Table 104. TransCure bioServices Revenue in Immuno-Oncology Service Business (2019-2024) & (US$ Million)

Table 105. TransCure bioServices Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Immuno-Oncology Service Picture

Figure 2. Global Immuno-Oncology Service Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Immuno-Oncology Service Market Share by Type: 2023 VS 2030

Figure 4. Basic Research Features

Figure 5. Clinical Research Features

Figure 6. Global Immuno-Oncology Service Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Immuno-Oncology Service Market Share by Application: 2023 VS 2030

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. Medical Device Companies Case Studies

Figure 10. Other Case Studies

Figure 11. Immuno-Oncology Service Report Years Considered

Figure 12. Global Immuno-Oncology Service Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Immuno-Oncology Service Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Immuno-Oncology Service Market Share by Region: 2023 VS 2030

Figure 15. Global Immuno-Oncology Service Market Share by Players in 2023

Figure 16. Global Top Immuno-Oncology Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Service as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Immuno-Oncology Service Revenue in 2023

Figure 18. North America Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Immuno-Oncology Service Market Share by Country (2019-2030)

Figure 20. United States Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Immuno-Oncology Service Market Share by Country (2019-2030)

Figure 24. Germany Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Immuno-Oncology Service Market Share by Region (2019-2030)

Figure 32. China Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Immuno-Oncology Service Market Share by Country (2019-2030)

Figure 40. Mexico Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Immuno-Oncology Service Market Share by Country (2019-2030)

Figure 44. Turkey Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Immuno-Oncology Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Crown Bioscience Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 48. Bio-Techne Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 49. Abcam Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 50. WuXi AppTec Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 51. Shanghai ChemPartner Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 52. George Clinical Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 53. Laboratory Corporation of America® Holdings Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 54. Medpace Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 55. Genscript Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 56. Shanghai Novamab Biopharmaceuticals Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 57. LIDE Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 58. TransCure bioServices Revenue Growth Rate in Immuno-Oncology Service Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immuno oncology Clinical Trials Market Research Report 2024

Oncology Immunotherapy Market

Immuno Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Immuno Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno Oncology Treatment Market Insights Forecast to 2030

Global Community Oncology Service Market Research Report 2024

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Immuno Cell Therapy Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Oncology Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Immunotherapy Drugs Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Immuno Oncology Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno Oncology Assays Kit Market Insights Forecast to 2030

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Cancer Immunotherapies Market Insights Forecast to 2030

Global Oncology EMR Software Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions